CymitQuimica logo

CAS 2414374-41-5

:

2H-1-Benzopyran-2-one, 3-(2-benzoxazolyl)-7-(diethylamino)-6-methyl-

Description:
2H-1-Benzopyran-2-one, 3-(2-benzoxazolyl)-7-(diethylamino)-6-methyl- is a synthetic organic compound characterized by its complex structure, which includes a benzopyran core fused with a benzoxazole moiety and a diethylamino group. This compound typically exhibits properties associated with both the benzopyran and benzoxazole functionalities, such as potential fluorescence and biological activity. The presence of the diethylamino group may enhance its solubility in organic solvents and influence its interaction with biological targets. The methyl group at the 6-position can affect the compound's steric and electronic properties, potentially impacting its reactivity and stability. As a member of the broader class of flavonoids, it may exhibit antioxidant properties and could be of interest in pharmaceutical research for its potential therapeutic applications. However, specific characteristics such as melting point, solubility, and spectral data would require empirical determination or literature references for precise values.
Formula:C21H20N2O3
Synonyms:
  • 2H-1-Benzopyran-2-one, 3-(2-benzoxazolyl)-7-(diethylamino)-6-methyl-
  • EMI56
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
  • EMI56
    Biosynth
    + Info

    EMI56

    CAS:
    <p>EMI56 is an analog that has shown potential as an anticancer agent. It is a kinase inhibitor that targets specific proteins involved in cancer cell growth and survival. EMI56 has been found to induce apoptosis, or programmed cell death, in human tumor cells and Chinese hamster ovary cells. This medicinal compound has demonstrated potent inhibitory activity against a variety of kinases, including those involved in the regulation of cell cycle progression and angiogenesis. EMI56 has also been detected in urine samples from cancer patients, suggesting its potential as a diagnostic tool for cancer detection and monitoring. As an inhibitor of kinases, EMI56 may offer a promising avenue for the development of new cancer therapies.</p>
    Formula:C21H20N2O3
    Purity:Min. 95%
    Molecular weight:348.4 g/mol

    Ref: 3D-PWD37441

    25mg
    1,155.00€
    50mg
    1,607.00€
  • EMI56
    Targetmol
    + Info

    EMI56

    CAS:
    <p>EMI56, a derivative of EMI1, exhibits enhanced potency against mutant EGFR compared to EMI1. Additionally, EMI56 effectively inhibits EGFR triple mutants[1].</p>
    Formula:C21H20N2O3
    Color and Shape:Solid
    Molecular weight:348.4

    Ref: TM-T35913